ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1832

Gut Dysbiosis Contributes to Autoimmune Pathogenesis in Lupus-Prone Mice

Seung Chul Choi1, Josephine Brown1, Mansour Mohamadzadeh2, Byron Croker1 and Laurence Morel3, 1Pathology, University of Florida, Gainesville, FL, 2Infectious Diseases & Pathology, University of Florida, Gainesville, FL, 3Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoantibodies and microbiome, Lupus, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Lupus Erythematosus – Animal Models

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Multiple studies have demonstrated that commensal bacteria play an immunoregulatory role and that gut dysbiosis is associated with inflammatory diseases. This study was conducted to test the hypothesis that gut dysbiosis plays a role in SLE. We have used a congenic model of lupus, the B6.Sle1.Sle2.Sle3 (TC) mice, which share >95% of their genome with B6 controls to ask if differences in microbiota between could synergize with lupus susceptibility genes to modulate autoimmune pathology.
Methods: The 16S rDNA sequences of fecal bacteria were compared between the two strains. Global fecal and serum metabolomic profiles were obtained using high-resolution mass spectrometry (Thermo Q-Exactive) coupled with ultra-high performance liquid chromatography. Tryptophan (Trp) metabolites were quantified with the same instruments relative to internal standards. Germ-free (GF) B6 mice were populated with fecal contents from either B6 or TC mice, and evaluated 4 weeks later. TC and B6 mice were treated with an antibiotic cocktail starting at 6 weeks of age and evaluated after 6 months of treatment. B6 and TC mice were either housed separately or co-housed in a mixed strains environment at weaning and evaluated 6 months later. B6 and TC mice were fed with Trp-deficient, Trp-supplemented (1%) and control chow starting at 2 months of age and evaluated 7 months later. Immunophenotypes were evaluated by flow cytometry. Serum and fecal antibodies were measured by ELISA. Kidney and gut pathology was evaluated by histology.
Results: TC and B6 mice have a different distribution of gut bacteria based on 16S rDNA sequencing. The colon and duodenum of aged TC mice showed a significant amount of immune cell infiltrate, which correlated with the severity of renal pathology. TC fecal transfers to GF B6 mice showed that microbiota from aged TC mice was sufficient to induce the production of serum anti-dsDNA IgG. TC microbiota also expanded germinal center (GC)-like organization in Peyer’s patches and follicular helper T (TFH) cells in the mesenteric lymph node. These changes were not observed with microbiota from young pre-disease TC mice. Treatment of TC mice with antibiotic cocktail significantly delayed anti-dsDNA IgG induction and expanded Treg and follicular regulatory T (TFR) cells. Co-housing TC and B6 mice revealed significant interactions between susceptibility genes and microbiota. Remarkably, the frequency of TFH cells was decreased in co-housed TC mice, corresponding to a drastic reduction of autoantibodies and amelioration of renal disease. Co-housed TC and B6 mice showed a similar fecal metabolome profile, which was significantly different from those of independently housed mice. Trp metabolites were among the metabolites found at different levels between TC and B6 stools. Similarly to what has been reported by others in SLE patients, TC mice have increased levels of serum and fecal kynurenine, one of Trp metabolites, as compared to B6. Accordingly, a Trp-supplemented chow accelerated autoimmune pathology in TC mice.
Conclusion: Overall, our results show that a dysregulated gut microbiota amplifies lupus pathogenesis in mice, and suggest that this is mediated at least in part by bacteria modifying Trp metabolism.


Disclosure: S. C. Choi, None; J. Brown, None; M. Mohamadzadeh, None; B. Croker, None; L. Morel, None.

To cite this abstract in AMA style:

Choi SC, Brown J, Mohamadzadeh M, Croker B, Morel L. Gut Dysbiosis Contributes to Autoimmune Pathogenesis in Lupus-Prone Mice [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/gut-dysbiosis-contributes-to-autoimmune-pathogenesis-in-lupus-prone-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-dysbiosis-contributes-to-autoimmune-pathogenesis-in-lupus-prone-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology